Additionally, in a study showing the induction of miR-4324 expression by ERα (70), bladder cancer sublines stably expressing miR-4324 were found to be significantly more sensitive to doxorubicin treatment than respective control sublines. The gene discussed is ESR1; the disease is urinary bladder cancer.